Navigation Links
Tougher Times May be Ahead for Biotechs: 1H12 Fundraising Slows
Date:7/9/2012

ATLANTA, July 9, 2012 /PRNewswire-USNewswire/ -- The amount of capital generated by private and public biotech companies slowed dramatically in the first half of 2012, with $7.9 billion raised, down 40 percent from the same period in 2011, according to analysis by BioWorld Insight.

(Logo: http://photos.prnewswire.com/prnh/20120628/DC32901LOGO)

It was a particularly tough second quarter with biotech companies collectively raising $2.76 billion, 46.4 percent less than the $5.15 billion raised in the first quarter this year and a whopping 62 percent down from the total raised in the second quarter of 2011.

"While it would be easy to explain away the decline in capital raised to date as a function of the sector being flush with cash, I would argue that the sheer magnitude of the drop off of funding is some cause for concern and is pointing to tougher times ahead for biotech," said BioWorld Insight Editor Peter Winter.

Based on BioWorld's data, the first half of 2012 saw U.S. biotech venture rounds bring in $877 million, a far cry from the $1.2 billion seen in same period last year. The number of deals wasn't the problem – there were 48 in each period – but there was a shift from Series B financings to the earlier round, which increased from 13 last year to 19 this year. The number of late round financings – Series C or later – remained the same year over year.

VCs could be cutting their losses early, but a more upbeat possibility is that there just aren't that many companies requiring Series B financing after the last few years of sluggish investments.

Today's edition of BioWorld Insight ‑ which provides behind-the-scenes analysis and commentary on the biotech marketplace ‑ delves into these trends, as well as the current status on the capital markets.

BioWorld Today, and its analytical companion, BioWorld Insight, are the biopharmaceutical industry's most respected news sources for more than two decades. To subscribe, call (800) 477-6307 or, outside the U.S., (404) 262-5476 or visit www.bioworld.com.


'/>"/>
SOURCE BioWorld
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. National Study: Teen "Heavy" Marijuana Use Up 80 Percent Since 2008, One in Ten Teens Reports Using Marijuana at Least 20 Times a Month
2. Nominations Open for San Francisco Business Times Health Care Heroes Awards
3. Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
4. In basic science, sometimes it takes individual benefactors like Roys Poyiadjis to fuel innovation
5. U.S. News & World Report and Pharmacy Times Announce "Top Recommended Health Products"
6. Nature Made Selected As "Top Recommended Health Product" By U.S. News & World Report And Pharmacy Times
7. With Busy Summer Forecast Ahead, More Hotels Are Raising Hygiene Standards, Says UMF Corporation
8. Frost & Sullivan: European Bipolar Therapeutics Market Slows Down in the Short Term As Key Blockbuster Drugs Go Off Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):